Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Nature Reviews. Immunology|February 16, 2013
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?Inessa Schwab, Falk NimmerjahnCell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk NimmerjahnAdvances in Therapy|November 20, 2019
The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational StudyJens Schreiber, Inessa Schwab Sauerbeck, Claudia MailänderSeminars in Immunopathology|March 23, 2012
The role of sialic acid as a modulator of the anti-inflammatory activity of IgGSybille Böhm, Inessa Schwab, Anja Lux, et al.Seminars in Immunopathology|April 30, 2014
Targeting B cells and autoantibodies in the therapy of autoimmune diseasesDaniela Kao, Anja Lux, Inessa Schwab, et al.Respiratory Medicine|November 30, 2020
Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in GermanyMarek Lommatzsch, Inessa Schwab Sauerbeck, Cristina Wilmer, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 9, 2020
Non-allergic severe asthma: is it really always non-allergic? The IDENTIFY projectDirk Koschel, Claudia Mailänder, Inessa Schwab Sauerbeck, et al.European Journal of Immunology|January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.European Journal of Immunology|September 5, 2012
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivoInessa Schwab, Michaela Seeling, Markus Biburger, et al.Expert Review of Clinical Immunology|March 7, 2012
FcγRIIB: a modulator of cell activation and humoral toleranceBirgit Lehmann, Inessa Schwab, Sybille Böhm, et al.Pageof 2